Compare LRN & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LRN | CRNX |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 4.1B |
| IPO Year | 2007 | 2018 |
| Metric | LRN | CRNX |
|---|---|---|
| Price | $66.19 | $47.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $113.25 | $71.00 |
| AVG Volume (30 Days) | ★ 1.2M | 992.2K |
| Earning Date | 01-27-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.30 | N/A |
| EPS | ★ 6.34 | N/A |
| Revenue | ★ $2,475,117,000.00 | $1,535,000.00 |
| Revenue This Year | $5.60 | $425.41 |
| Revenue Next Year | $4.69 | $943.30 |
| P/E Ratio | $10.44 | ★ N/A |
| Revenue Growth | 17.25 | ★ 47.74 |
| 52 Week Low | $60.62 | $24.10 |
| 52 Week High | $171.17 | $54.18 |
| Indicator | LRN | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 41.43 | 54.60 |
| Support Level | $65.00 | $43.04 |
| Resistance Level | $66.78 | $49.61 |
| Average True Range (ATR) | 1.85 | 2.04 |
| MACD | 1.85 | -0.16 |
| Stochastic Oscillator | 77.89 | 62.22 |
Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional and Private Pay Schools and Other.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.